Active substance : montelukast
Form : chewable tablets
Dosage : 5 mg per tablet
Packaging : Box with 28 tablets (2 blisters of 14 chewable tablets)
Target : children from 6 to 14 years
Alukon is indicated in the treatment of asthma as add-on therapy in those patients with mild to moderate persistent asthma who are inadequately controlled on inhaled corticosteroids and in whom ‘as-needed’ short acting beta-agonists provide inadequate clinical control of asthma.
Alukon can also be an alternative to low-dose inhaled corticoids in patients with mild persistent asthma with no recent history of severe asthma attacks requiring oral corticoid therapy, and who have demonstrated inability to adhere to inhaled corticoid therapy.
Alukon is also indicated in the prophylaxis of asthma in which the predominant component is exercise-induced bronchoconstriction.
Patients from 6 to 14 years of age
One (1) chewable tablet of 5 mg/day , to be taken in the evening.
Prescription drugs. Please contact your doctor.
